Axsome Therapeutics, Inc. AXSM
NASDAQ · United States · Health Technology
$183.50-0.89 (-0.48%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.99 | -0.89 | -11.0% | $216.36M | -2.2% | +1.4%$212.74→$215.77 |
| Q1 2026 | 2026-05-04 | -1.26 | -0.86 | -46.5% | — | — | +8.0%$206.53→$223.06 |
| Q4 2025 | 2026-02-23 | -0.56 | -0.73 | +23.3% | — | — | -7.5%$183.72→$169.95 |
| Q3 2025 | 2025-11-03 | -0.94 | -0.90 | -4.4% | — | — | 0.0%$134.99→$134.93 |
| Q2 2025 | 2025-08-04 | -0.97 | -1.09 | +11.0% | — | — | — |
| Q1 2025 | 2025-05-05 | -1.22 | -1.35 | +9.6% | — | — | — |
| Q4 2024 | 2025-02-18 | -1.54 | -1.05 | -46.7% | — | — | — |
| Q3 2024 | 2024-11-12 | -1.34 | -1.39 | +3.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.